Sales & Earnings In Brief
This article was originally published in The Tan Sheet
Executive Summary
Consumer health drives Bayer HealthCare
You may also be interested in...
In Brief
Consent decree follows claim warning
In Brief
Abbott's Ensure claims convince NAD
GlaxoSmithKline's OTC Garage Sale Includes alli, FiberChoice
GlaxoSmithKline includes the alli weight-loss brand in its planned divestment of international OTCs worth about $813 million in 2010 sales, or 10% of the firm's total Consumer Healthcare business.